Article citationsMore>>

Cai, H., Chiorean, E.G., Chiorean, M.V., Rex, D.K., Robb, B.W., Hahn, N.M., Liu, Z., Loehrer, P.J., Harrison, M.L. and Xu, Y. (2013) Elevated phospholipase A2 activities in plasma samples from multiple cancers. PLoS One, 8.
http://dx.doi.org/10.1371/journal.pone.0057081

has been cited by the following article:

• TITLE: Patatin-like PLA2 with cytotoxicity against mammalian and plant tumour cells

  AUTHORS: Bernard Griffaut, Eric Debiton, Marie-Josèphe Galmier, Ana Mustel, Jean-Claude Madelmont, Gérard Ledoigt

  KEYWORDS: Cytotoxicity; Patatin; Phospholipase A2

  JOURNAL NAME: Advances in Biological Chemistry, Vol.3 No.5, October 24, 2013

  ABSTRACT: Plants can respond to traumatism by synthesis and secretion of defence molecules. Wound-healing and desiccation stress of pieces of potato tuber parenchyma (Solanum tuberosum) promoted the secretion of a patatin-like phospholipase A2, PLA2 (EC.3.1.1.4.) that displayed cytotoxic activity against tumour cells. The potato secretion product, an oligomeric form of patatin-like protein, was shown to contain several isoforms of PLA2 polypeptides and to be associated with other proteins, including Kunitz-type protease inhibitors. Patatin-like protein secretion was inhibited by vanadate. Secreted patatin-like proteins displayed specific features, such as extracellular function and low molecular weights, mainly 36 to 40 kDa. The 36-kDa polypeptide sequence was related to iPLA2α. Polypeptide spots of secreted patatin-like protein exhibited a nucleotide-binding consensus motif, GGGIKG that has been described in iPLA2 gene family. The cytotoxic agent caused cell death of plant crown-gall induced by Agrobacterium tumefaciens, and inhibited B16 cell proliferation, but at the same concentration did not display any toxicity against non-transformed cells. PLA2 enzyme activity was required for cytotoxicity against B16 melanoma cells. A model for such a specific activity against tumour cells is discussed in connection with asymmetric phospholipid patterns of cell membranes. In conclusion, secreted patatin-like PLA2 (e-patatin) may represent a novel therapeutic target for the development of new agents against cancer.